Skip to content
Screener

Weyco Group WEYS Total Equity

Discontinued — last reported Q1 '19

Total Equity at other companies

GPA
General Purpose Acquisition Corp.GPAC
-$7.87M+38.7%
Veradermics logo
VeradermicsMANE
$390.64M+744%
BK
BKBK
$44.78B+3.9%
Polaryx Therapeutics, Inc. logo
Polaryx Therapeutics, Inc.PLYX
$2.49M-41.5%
Schering-Plough logo
Schering-PloughSGP
$250.11M+463%
Dollar General logo
Dollar GeneralDG
$8.84B+14.8%

Other financials

Income statement

See full
Revenue$62.2M+6.9%
Gross profit$43.8M+73.6%
Operating income$17.0M+337%
Net income$13.3M+490%
EPS (diluted)$1.39+479%

Balance sheet

See full
Cash & equivalents$93.7M+21.0%
Total debt$9.1M-28.2%
Total assets$311.1M+3.4%

Cash flow

See full
Operating cash flow$7.7M-24.3%
CapEx$936.0K+260%
Free cash flow$6.8M-31.7%

Valuation

See full
Market cap$440.1M+52.9%
Enterprise value$355.52M+59.4%
P/E12.7×+1.6×
P/S1.6×+0.5×

Profitability

See full
Gross margin49.1%+3.9pp
Operating margin15.3%+3.7pp
Net margin12.4%+3.2pp
FCF margin16.7%+4.8pp

Returns & leverage

See full
Return on equity10.5%—
Debt / equity0.1×—
Current ratio7.5×-1.4×

Where this comes from

Reported directly by Weyco Group in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest.

The source filing: Weyco Group’s 10-Q, filed May 9, 2019. Open the filing →

Filed
May 9, 2019
Fiscal quarter
Q1 FY2019
Calendar quarter
Q1 2019
Accession
0001144204-19-024849

FAQ

What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.